Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/50553
Campo DC Valoridioma
dc.contributor.authorPérez-Labrada, Karellen_US
dc.contributor.authorBrouard Martín,Ignacioen_US
dc.contributor.authorEstévez, Saraen_US
dc.contributor.authorMarrero, María Teresaen_US
dc.contributor.authorEstevez, Franciscoen_US
dc.contributor.authorBermejo, Jaimeen_US
dc.contributor.authorRivera, Daniel G.en_US
dc.contributor.otherEstevez, Francisco-
dc.contributor.otherBrouard, Ignacio-
dc.date.accessioned2018-11-24T16:56:45Z-
dc.date.available2018-11-24T16:56:45Z-
dc.date.issued2012en_US
dc.identifier.issn0968-0896en_US
dc.identifier.urihttp://hdl.handle.net/10553/50553-
dc.description.abstractA variety of spirostan saponins and related glycosides were synthesized and evaluated for their cytotoxicity against the human myeloid leukemia cell line (HL-60). A linear glycosylation strategy allowed for accessing a variety of functionalization patterns at both the spirostanic and the saccharide moieties, which provides new information regarding the structure-cytotoxicity relationship of this family of steroidal glycosides. Intriguing results were achieved with respect to hecogenyl and 5 alpha-hydroxy-laxogenyl beta-chacotriosides, turning out to be the former very cytotoxic and the latter no cytotoxic at all. Importantly, the partially pivaloylated beta-D-glucosides of 5 alpha-hydroxy-laxogenin were the most potent cytotoxic compounds among all tested glycosides. This comprises the first report on acylated spirostanyl glucosides displaying significant cytotoxicity, and therefore, it opens up new opportunities toward the development of saponin analogues as anticancer agents.en_US
dc.languageengen_US
dc.relationEvaluación de Potenciales Compuestos Antileucémicos.en_US
dc.relation.ispartofBioorganic and Medicinal Chemistryen_US
dc.sourceBioorganic & Medicinal Chemistry[ISSN 0968-0896],v. 20 (8), p. 2690-2700en_US
dc.subject32 Ciencias médicasen_US
dc.subject2403 Bioquímicaen_US
dc.subject.otherSolanum Steroidal Glycosidesen_US
dc.subject.otherDiosgenyl Saponinsen_US
dc.subject.otherHemolytic-Activityen_US
dc.subject.otherTriterpenoid Saponinsen_US
dc.subject.otherDioscin Derivativesen_US
dc.subject.otherDracaena-Dracoen_US
dc.subject.otherPolyphyllin-Den_US
dc.subject.otherChacotriosylen_US
dc.subject.otherApoptosisen_US
dc.subject.otherCellsen_US
dc.titleNew insights into the structure-cytotoxicity relationship of spirostan saponins and related glycosidesen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.bmc.2012.02.026en_US
dc.identifier.scopus84859420523-
dc.identifier.isi000302767100026-
dcterms.isPartOfBioorganic & Medicinal Chemistry-
dcterms.sourceBioorganic & Medicinal Chemistry[ISSN 0968-0896],v. 20 (8), p. 2690-2700-
dc.contributor.authorscopusid23987128500-
dc.contributor.authorscopusid6603470039-
dc.contributor.authorscopusid53867837200-
dc.contributor.authorscopusid55055343200-
dc.contributor.authorscopusid7003810011-
dc.contributor.authorscopusid7101636723-
dc.contributor.authorscopusid7006738211-
dc.description.lastpage2700en_US
dc.description.firstpage2690en_US
dc.relation.volume20en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.identifier.wosWOS:000302767100026-
dc.contributor.daisngid3572761-
dc.contributor.daisngid657275-
dc.contributor.daisngid4613160-
dc.contributor.daisngid2743847-
dc.contributor.daisngid384944-
dc.contributor.daisngid5695465-
dc.contributor.daisngid388593-
dc.identifier.investigatorRIDK-5125-2014-
dc.identifier.investigatorRIDK-5175-2014-
dc.description.numberofpages11en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Perez-Labrada, K-
dc.contributor.wosstandardWOS:Brouard, I-
dc.contributor.wosstandardWOS:Estevez, S-
dc.contributor.wosstandardWOS:Marrero, MT-
dc.contributor.wosstandardWOS:Estevez, F-
dc.contributor.wosstandardWOS:Bermejo, J-
dc.contributor.wosstandardWOS:Rivera, DG-
dc.date.coverdateAbril 2012en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr1,2-
dc.description.jcr2,903-
dc.description.sjrqQ1-
dc.description.jcrqQ2-
dc.description.scieSCIE-
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.project.principalinvestigatorEstévez Rosas, Francisco Jesús-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.orcid0000-0002-9728-2774-
crisitem.author.orcid0000-0002-9728-2774-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameBrouard Martín, Ignacio-
crisitem.author.fullNameEstévez Rosas, Francisco Jesús-
crisitem.author.fullNameEstévez Rosas, Francisco Jesús-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

22
actualizado el 17-nov-2024

Citas de WEB OF SCIENCETM
Citations

22
actualizado el 17-nov-2024

Visitas

62
actualizado el 27-ene-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.